Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Egyla Cavalcante"'
Autor:
Elyse Moritz Sacconato, Otavio C. G. Baiocchi, Egyla Cavalcante, Joao Garibaldi, Priscilla Brito Silva, Guilherme Fleury Perini, Luciana de Andrade Pereira, Adriana M. Damasco Penna
Publikováno v:
Clinical lymphoma, myelomaleukemia.
Classical Hodgkin lymphoma (cHL) is a malignant lymphoma that most commonly affects young adults. The lymphomagenesis of cHL depends largely on immune alterations that contribute to proliferation and maintenance of the Hodgkin-Reed-Sternberg (HRS) ne
Autor:
Juliana Monte Real, Otavio C. G. Baiocchi, Adriana M. Damasco Penna, Fabio Nascimento Brito, Gustavo H. Esteves, Ludmila Rodrigues Pinto Ferreira, Priscilla Brito Silva, Egyla Cavalcante, Joao Garibaldi Junior
Publikováno v:
Blood. 128:5298-5298
Introduction: Molecular alterations involved in development of classical Hodgkin lymphoma (cHL) are only partially known. Genetic alterations in NFkB pathway and the imbalance of T regulatory (Treg) and TH17 lymphocytes has been recognized as critica
Autor:
Fabio Nascimento Brito, Juliana Monte Real, Ludmila Rodrigues Pinto Ferreira, Priscilla Brito Silva, Gustavo H. Esteves, Otavio C. G. Baiocchi, Egyla Cavalcante, Adriana M. Damasco Penna, Joao Garibaldi Junior
Publikováno v:
Blood. 128:5290-5290
Introduction: Interleukin (IL)-10 is an anti-inflammatory cytokine with potent inhibitory effects in immune response. Higher expression of IL-10 has also been detected in classical Hodgkin lymphoma (cHL), and it has been suggested that the cytokine i
Autor:
Gustavo H. Esteves, Fabio Nascimento Brito, Joao Garibaldi Junior, Ludmila Rodrigues Pinto Ferreira, Egyla Cavalcante, Priscilla Brito Silva, Juliana Monte Real, Otavio C. G. Baiocchi, Adriana M. Damasco Penna
Publikováno v:
Blood. 128:5294-5294
Introduction: Although immunosuppression has long been recognized in classical Hodgkin lymphoma (cHL), the underlying basis for this lack of an effective immune response against tumor remains unclear. Recently, our group showed increased frequencies
Autor:
Otavio C. G. Baiocchi, Joao Joao Garibaldi Rezende, Egyla Cavalcante, Fabio P.S. Santos, Priscilla Brito Silva, Adriana M. Damasco Penna, Guilherme Fleury Perini
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:S222-S223
S222 in other PTCL with different CD30 expression levels. The aim of the study was to investigate the efficacy of BV in patients with relapsed or refractory PTCL. Methods: From March 2011 to January 2014, 74 patients were treated with BV in France in
Autor:
Maria Mirtes Sales, Adriana M. Damasco Penna, Egyla Cavalcante, Elma Maria Chaves, Priscilla Brito Silva, Otavio C. G. Baiocchi, Joyce M. K. Silva, Joao Garibaldi Rezende Jr.
Publikováno v:
Blood. 122:1756-1756
Introduction Although immunosuppression has long been recognized in classical Hodgkin lymphoma (cHL), the underlying basis for the lack of an effective immune response against the tumor remains unclear. Increased frequencies of regulatory CD4+ T lymp
Autor:
Fabio S P Santos, Eni Maria Souza, Guilherme Fleury Perini, Otavio C. G. Baiocchi, Davimar Miranda Maciel Borducchi, Karin Zattar Cecyn, Nelson Hamerschlak, Danielle Leao Cordeiro Faria, Fernanda Cunha Vieira, Renato Tavares, João Garibaldi de Rezende, Camila Almeida Amaral, Egyla Cavalcante, Adriana M. Damasco Penna
Publikováno v:
Blood. 122:4236-4236
Introduction Classical Hodgkin lymphoma (cHL) is one of the most curable cancers, with cure rates ranging from 65-90%, depending on different risk factors. These factors include both clinical (international prognostic score, IPS) and biological marke